How well patients stick with a new bowel disease treatment

This is a real-world study looking at how well patients stick with guselkumab, a newer medication for moderate-to-severe ulcerative colitis and Crohn's disease. The study is not testing a new drug or asking you to do anything different from your normal treatment—instead, researchers will collect information from your regular doctor visits and medical records to understand how long people continue taking this medication and how well it works for them.

Doctors need to understand whether patients keep taking this medication over time and how effective it really is when used in everyday medical practice, rather than just in carefully controlled research settings. This information helps doctors decide if this treatment is a good option for their patients with these difficult-to-treat bowel conditions.